Anti-β2GP1, the pathologic antibodies implicated in APS, have been reported to activate multiple cellular components in the circulation, including platelets, endothelium, and neutrophils (4, 5, 11, 12, 40). This evidence concerns the gene APOH and autoimmune polyendocrinopathy.